Moreover, higher CTRP3 levels were found in the infarct border region after injection of CTRP3-overexpressing MSCs, implying that MSCs may provide improved drug delivery after MI than previously reported drug delivery vehicles (e.g., adenovirus or direct protein administration)9–11,34. This evidence concerns the gene C1QTNF3 and myocardial infarction.